SlideShare a Scribd company logo
February 25, 2020
Kathy Lofy, MD
State Health Officer / Chief Science Officer
2
Overview
Background
International, national, and local situation
Characteristics of COVID-19
Public health activities underway
Guidance for schools
Addressing and fighting stigma
3
Background
 COVID-19 is the name of the “novel coronavirus” disease
 SARS-CoV-2 is the name of the virus that causes COVID-19
 Coronaviruses cause mild respiratory illnesses, such as the
common cold
o Severe Acute Respiratory Syndrome (SARS)
o Middle East Respiratory Syndrome (MERS)
 COVID-19 is a new coronavirus disease
 Emerged from Hubei Province, China in December 2019
 The immediate risk to the general public in Washington
state and the U.S. is low
4
INTERNATIONAL, NATIONAL, AND LOCAL
SITUATION
5
International Situation
Total confirmed cases: 79,331
o 77,262 cases from mainland China (2595 deaths)
o 2069 cases from 29 other countries (23 deaths)
*numbers current as of 2/24/20
Source: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
6
International Situation
 Reporting sustained community transmission (Level 2/3 alert)
o China
o Japan
o South Korea
 Reporting some community transmission (Level 1 alert)
o Hong Kong
o Iran
o Italy
 Apparent community transmission
o Singapore
o Taiwan
o Thailand
o Vietnam
*numbers current as of 2/24/20
Source: https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html
https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
7
53 Confirmed Cases among US Residents
*numbers current as of 2/24/20
Source: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
8
Washington Situation
Confirmed cases: 1 (plus 4 cases at Sacred Heart Medical
Center in Spokane)
Persons Under Investigation (PUI): 2
Number of people under public health supervision*: 582
*The number of people at risk of having been exposed to the SARS-CoV-2 virus
who are monitoring their health under the supervision of public health officials.
This includes close contacts of laboratory confirmed cases and persons who have
returned from China in the past 14 days.
Ongoing incident management team and command
center activated January 21 at the department’s Public
Health Laboratories
*numbers current as of 2/24/20
Source: https://www.doh.wa.gov/Emergencies/Coronavirus
9
Screening at Sea-Tac International Airport
All travelers from China funneled to 11 airports
(including SeaTac) and screened for fever and
respiratory symptoms
Travelers arriving at Sea-Tac International Airport
o If ill  isolation and evaluation
o If asymptomatic and from Hubei Province 
quarantine with active health monitoring
(none in Washington)
o If asymptomatic from China (non-Hubei) 
self-monitoring at home with public health
supervision, asked to avoid public settings
including school and work
10
COVID-19 CHARACTERISTICS
11
What are the symptoms?
 Fever
 Cough
 Shortness of breath
Source: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
12
Risk Factors and Severity
 People with COVID-19 can have no symptoms or
develop mild, severe, or fatal illness
 Kids may have less severe disease (2% of confirmed
cases in China occurred among those <20 years old)
 Current case fatality rate ~2% among those with
laboratory-confirmed COVID-19
 Risk factors for severe illness may include:
o Older age
o Underlying chronic medical conditions
Source: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
13
How does the virus spread?
 Primarily spreads person-to-person via respiratory droplets
from coughs or sneezes (like the flu)
 Possibly spread by touching an object or surface with the
virus on it, then touching mouth, nose, or eyes
 Possibly spread through stool with the virus in it
 It takes approximately 2 to 14 days (median ~5 days) for
an infected person to show symptoms
 People likely most infectious while they are most
symptomatic (e.g., coughing and sneezing)
o Spread from people without symptoms appears
possible
14
Treatment and Vaccine
 Treatment
o No specific treatment currently available
o Supportive management of complications, including
advanced organ support if indicated
o Anti-viral medications under investigation
 Vaccines are under development
o Phase 1 trials in people may occur within 2 months
15
Risk Assessment
Serious public health threat to the United States
Low health risk for COVID-19 to the general
public in the US and Washington at this time
Strategy now is to slow the spread of the virus
(i.e., contain the virus) so that we have time to:
o Prepare the healthcare system and the general public
o Better characterize the infection to guide public health
recommendations and development of medical
countermeasures including diagnostics, therapeutics,
and vaccines
“Current global circumstances suggest it is likely
that this virus will cause a pandemic”
Source: https://www.cdc.gov/coronavirus/2019-nCoV/summary.html#risk-assessment
16
Goals of Community Mitigation for
Pandemic Influenza
Source: CDC. MMWR 2017;66(1):1–34. (https://www.cdc.gov/mmwr/volumes/66/rr/rr6601a1.htm
17
Community Mitigation Planning
(Non-pharmaceutical Interventions)
Strategies
o Personal
■Home isolation of ill people, hand hygiene,
resp. etiquette
■Home quarantine of well, potentially
exposed people
o Social distancing
■School closures and dismissals
■Social distancing in workplaces
■Postponing or cancelling mass gatherings
o Environmental measures (e.g., routine
cleaning of frequently touched surfaces)
Source: CDC. MMWR 2017;66(1):1–34.
18
GUIDANCE FOR SCHOOLS
19
When should students, staff or volunteers seek
medical evaluation?
Criteria
Ill with a fever, cough, or difficulty breathing
AND have traveled from China in the last 14
days
Ill with fever, cough, difficulty breathing AND
have been identified by public health officials
as a recent close contact of a confirmed
COVID-19 case or had recent close contact
with someone who is being evaluated for
COVID-19 infection
These criteria are likely to change!
20
Procedure for students, staff, or volunteers
meeting criteria
Move them to a private room away from others
and ask them to wear a face mask
Immediately notify your local health
department for guidance
21
Recommendations for students, staff, or
volunteers arriving in the US from China
AFTER February 2, 2020 at 2 p.m.
o Stay at home, away from others, and monitor
their health for 14 days
o If they develop symptoms during the 14-day
period, avoid contact with others. Call the
doctor or health care provider to update
them on symptoms and recent travel.
These criteria are likely to change!
22
Reduce risk at school
You do not need to take special precautions
Encourage students and staff to:
o Stay home when sick
o Perform frequent hand washing with soap & water
(If not available, use alcohol-based hand sanitizer)
o Avoid touching eyes/nose/mouth with unwashed
hands
o Cover coughs/sneezes with a tissue, then throw
tissue in trash and clean hands with soap/water (or
hand sanitizer)
o Provide adequate supplies for good hygiene
o Follow your routine cleaning and disinfection
program
23
Cleaning and Disinfecting Procedures
 Routinely clean with a third party “green” certified
cleaner and disinfect with an EPA‐registered product
with a disinfectant claim for human coronaviruses
 Typically, this means daily sanitizing surfaces and objects
frequently touched (e.g., bathrooms, water coolers,
desks, doorknobs, computer keyboards, hands‐on
learning items, faucet handles, phones, toys, etc.)
 Clean the surface first to remove all organic matter
 Follow the disinfectant manufacturer’s instructions:
o Use the proper concentration of disinfectant
o Allow the required wet contact time
o Pay close attention to hazard warnings and instructions
for using personal protective items
o Use disinfectants in a sufficiently ventilated space
24
Strategies to Counter Stigma
 Rely on and share trusted sources of
information.
 Speak up if you hear, see, or read
stigmatizing or harassing comments or
misinformation.
 Show compassion and support for
individuals and communities more
closely impacted.
 Avoid stigmatizing people who are in
quarantine. They are making the right
choice for their communities.
 Do not make assumptions about
someone’s health status based on their
ethnicity, race or national origin.
What we can
do as
individuals
25
Strategies to Counter Stigma
 Stay updated and informed on COVID-
19 to avoid miscommunication or
inaccurate information
 Talk openly about the harm of stigma
 View people directly impacted by
stigma as people first
 Be conscious of your language
 Acknowledge access & language
barriers
 Check your own stigmas and biases
 Support community with where to
access credible information
 Be transparent about COVID-19
 Stick to the facts
What we can
do as
professionals
Viruses don’t
discriminate and
neither should we
Washington State Department of Health is committed to providing customers with forms
and publications in appropriate alternate formats. Requests can be made by calling
800-525-0127 or by email at civil.rights@doh.wa.gov. TTY users dial 711.

More Related Content

Similar to COVIDSchoolsPresentation-2-25-20.pdf

Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGYCovid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Dr. Madhu Kiran
 
Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)
Brunswick County
 
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
Shivam Parmar
 
Evidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsEvidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patients
Saren Azer
 
Nurse's fight against Corona Virus ( Covid 19 )
Nurse's fight against Corona Virus ( Covid 19 )Nurse's fight against Corona Virus ( Covid 19 )
Nurse's fight against Corona Virus ( Covid 19 )
ArghieIscala
 
Covid 19-ppt
Covid 19-pptCovid 19-ppt
Covid 19-ppt
Nityant Singhal
 
NIH Environmental Science Training Tool for COVID-19
NIH Environmental Science Training Tool for COVID-19 NIH Environmental Science Training Tool for COVID-19
NIH Environmental Science Training Tool for COVID-19
The Windsdor Consulting Group, Inc.
 
Corona virus 2020 what need know
Corona virus 2020 what need knowCorona virus 2020 what need know
Corona virus 2020 what need know
RomasTamosevicius
 
WHO COVID-19 Guidelines
WHO COVID-19 GuidelinesWHO COVID-19 Guidelines
WHO COVID-19 Guidelines
Henrique Diez Botelho
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
Amar joseph
 
Covid -19
Covid -19Covid -19
Covid -19
MrSanny
 
Covid 19 surveillance
Covid 19 surveillanceCovid 19 surveillance
Covid 19 surveillance
NOORISLAMBAG
 
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار
 
Coronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-versionCoronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-version
د حاتم البيطار
 
Covid19 course د حاتم البيطار
Covid19 course  د حاتم البيطارCovid19 course  د حاتم البيطار
Covid19 course د حاتم البيطار
د حاتم البيطار
 
Covid-19
Covid-19Covid-19
Covid-19
DoctorGulzar
 
Coronavirus (COVID-19)
Coronavirus (COVID-19) Coronavirus (COVID-19)
Coronavirus (COVID-19)
Belachew Weldegebriel
 
COVID 19 AWARENESS
COVID 19 AWARENESSCOVID 19 AWARENESS
COVID 19 AWARENESS
JoyMaeBaingan1
 
Coronavirus diseases
Coronavirus diseasesCoronavirus diseases
Coronavirus diseases
assam down town university
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )
VivekKumar3314
 

Similar to COVIDSchoolsPresentation-2-25-20.pdf (20)

Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGYCovid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
Covid 19 Dr. MADHUKIRAN, MD.PULMONOLOGY
 
Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)Coronavirus Disease 2019 (COVID-19)
Coronavirus Disease 2019 (COVID-19)
 
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
COVID-19: A guide for Medical Officers in Primary Health Centres. All Details...
 
Evidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patientsEvidance based managment of COVID-19 patients
Evidance based managment of COVID-19 patients
 
Nurse's fight against Corona Virus ( Covid 19 )
Nurse's fight against Corona Virus ( Covid 19 )Nurse's fight against Corona Virus ( Covid 19 )
Nurse's fight against Corona Virus ( Covid 19 )
 
Covid 19-ppt
Covid 19-pptCovid 19-ppt
Covid 19-ppt
 
NIH Environmental Science Training Tool for COVID-19
NIH Environmental Science Training Tool for COVID-19 NIH Environmental Science Training Tool for COVID-19
NIH Environmental Science Training Tool for COVID-19
 
Corona virus 2020 what need know
Corona virus 2020 what need knowCorona virus 2020 what need know
Corona virus 2020 what need know
 
WHO COVID-19 Guidelines
WHO COVID-19 GuidelinesWHO COVID-19 Guidelines
WHO COVID-19 Guidelines
 
Covid 19 (corona virus)
Covid 19 (corona virus)Covid 19 (corona virus)
Covid 19 (corona virus)
 
Covid -19
Covid -19Covid -19
Covid -19
 
Covid 19 surveillance
Covid 19 surveillanceCovid 19 surveillance
Covid 19 surveillance
 
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
د حاتم البيطار Coronavirus covid19-nursing-professional-post-acute-care-text-...
 
Coronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-versionCoronavirus covid19-nursing-professional-post-acute-care-text-version
Coronavirus covid19-nursing-professional-post-acute-care-text-version
 
Covid19 course د حاتم البيطار
Covid19 course  د حاتم البيطارCovid19 course  د حاتم البيطار
Covid19 course د حاتم البيطار
 
Covid-19
Covid-19Covid-19
Covid-19
 
Coronavirus (COVID-19)
Coronavirus (COVID-19) Coronavirus (COVID-19)
Coronavirus (COVID-19)
 
COVID 19 AWARENESS
COVID 19 AWARENESSCOVID 19 AWARENESS
COVID 19 AWARENESS
 
Coronavirus diseases
Coronavirus diseasesCoronavirus diseases
Coronavirus diseases
 
COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )COVID-19 ( A Report of 2019 )
COVID-19 ( A Report of 2019 )
 

Recently uploaded

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 

Recently uploaded (20)

How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 

COVIDSchoolsPresentation-2-25-20.pdf

  • 1. February 25, 2020 Kathy Lofy, MD State Health Officer / Chief Science Officer
  • 2. 2 Overview Background International, national, and local situation Characteristics of COVID-19 Public health activities underway Guidance for schools Addressing and fighting stigma
  • 3. 3 Background  COVID-19 is the name of the “novel coronavirus” disease  SARS-CoV-2 is the name of the virus that causes COVID-19  Coronaviruses cause mild respiratory illnesses, such as the common cold o Severe Acute Respiratory Syndrome (SARS) o Middle East Respiratory Syndrome (MERS)  COVID-19 is a new coronavirus disease  Emerged from Hubei Province, China in December 2019  The immediate risk to the general public in Washington state and the U.S. is low
  • 5. 5 International Situation Total confirmed cases: 79,331 o 77,262 cases from mainland China (2595 deaths) o 2069 cases from 29 other countries (23 deaths) *numbers current as of 2/24/20 Source: https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  • 6. 6 International Situation  Reporting sustained community transmission (Level 2/3 alert) o China o Japan o South Korea  Reporting some community transmission (Level 1 alert) o Hong Kong o Iran o Italy  Apparent community transmission o Singapore o Taiwan o Thailand o Vietnam *numbers current as of 2/24/20 Source: https://www.cdc.gov/coronavirus/2019-ncov/travelers/index.html https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
  • 7. 7 53 Confirmed Cases among US Residents *numbers current as of 2/24/20 Source: https://www.cdc.gov/coronavirus/2019-ncov/cases-in-us.html
  • 8. 8 Washington Situation Confirmed cases: 1 (plus 4 cases at Sacred Heart Medical Center in Spokane) Persons Under Investigation (PUI): 2 Number of people under public health supervision*: 582 *The number of people at risk of having been exposed to the SARS-CoV-2 virus who are monitoring their health under the supervision of public health officials. This includes close contacts of laboratory confirmed cases and persons who have returned from China in the past 14 days. Ongoing incident management team and command center activated January 21 at the department’s Public Health Laboratories *numbers current as of 2/24/20 Source: https://www.doh.wa.gov/Emergencies/Coronavirus
  • 9. 9 Screening at Sea-Tac International Airport All travelers from China funneled to 11 airports (including SeaTac) and screened for fever and respiratory symptoms Travelers arriving at Sea-Tac International Airport o If ill  isolation and evaluation o If asymptomatic and from Hubei Province  quarantine with active health monitoring (none in Washington) o If asymptomatic from China (non-Hubei)  self-monitoring at home with public health supervision, asked to avoid public settings including school and work
  • 11. 11 What are the symptoms?  Fever  Cough  Shortness of breath Source: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
  • 12. 12 Risk Factors and Severity  People with COVID-19 can have no symptoms or develop mild, severe, or fatal illness  Kids may have less severe disease (2% of confirmed cases in China occurred among those <20 years old)  Current case fatality rate ~2% among those with laboratory-confirmed COVID-19  Risk factors for severe illness may include: o Older age o Underlying chronic medical conditions Source: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html
  • 13. 13 How does the virus spread?  Primarily spreads person-to-person via respiratory droplets from coughs or sneezes (like the flu)  Possibly spread by touching an object or surface with the virus on it, then touching mouth, nose, or eyes  Possibly spread through stool with the virus in it  It takes approximately 2 to 14 days (median ~5 days) for an infected person to show symptoms  People likely most infectious while they are most symptomatic (e.g., coughing and sneezing) o Spread from people without symptoms appears possible
  • 14. 14 Treatment and Vaccine  Treatment o No specific treatment currently available o Supportive management of complications, including advanced organ support if indicated o Anti-viral medications under investigation  Vaccines are under development o Phase 1 trials in people may occur within 2 months
  • 15. 15 Risk Assessment Serious public health threat to the United States Low health risk for COVID-19 to the general public in the US and Washington at this time Strategy now is to slow the spread of the virus (i.e., contain the virus) so that we have time to: o Prepare the healthcare system and the general public o Better characterize the infection to guide public health recommendations and development of medical countermeasures including diagnostics, therapeutics, and vaccines “Current global circumstances suggest it is likely that this virus will cause a pandemic” Source: https://www.cdc.gov/coronavirus/2019-nCoV/summary.html#risk-assessment
  • 16. 16 Goals of Community Mitigation for Pandemic Influenza Source: CDC. MMWR 2017;66(1):1–34. (https://www.cdc.gov/mmwr/volumes/66/rr/rr6601a1.htm
  • 17. 17 Community Mitigation Planning (Non-pharmaceutical Interventions) Strategies o Personal ■Home isolation of ill people, hand hygiene, resp. etiquette ■Home quarantine of well, potentially exposed people o Social distancing ■School closures and dismissals ■Social distancing in workplaces ■Postponing or cancelling mass gatherings o Environmental measures (e.g., routine cleaning of frequently touched surfaces) Source: CDC. MMWR 2017;66(1):1–34.
  • 19. 19 When should students, staff or volunteers seek medical evaluation? Criteria Ill with a fever, cough, or difficulty breathing AND have traveled from China in the last 14 days Ill with fever, cough, difficulty breathing AND have been identified by public health officials as a recent close contact of a confirmed COVID-19 case or had recent close contact with someone who is being evaluated for COVID-19 infection These criteria are likely to change!
  • 20. 20 Procedure for students, staff, or volunteers meeting criteria Move them to a private room away from others and ask them to wear a face mask Immediately notify your local health department for guidance
  • 21. 21 Recommendations for students, staff, or volunteers arriving in the US from China AFTER February 2, 2020 at 2 p.m. o Stay at home, away from others, and monitor their health for 14 days o If they develop symptoms during the 14-day period, avoid contact with others. Call the doctor or health care provider to update them on symptoms and recent travel. These criteria are likely to change!
  • 22. 22 Reduce risk at school You do not need to take special precautions Encourage students and staff to: o Stay home when sick o Perform frequent hand washing with soap & water (If not available, use alcohol-based hand sanitizer) o Avoid touching eyes/nose/mouth with unwashed hands o Cover coughs/sneezes with a tissue, then throw tissue in trash and clean hands with soap/water (or hand sanitizer) o Provide adequate supplies for good hygiene o Follow your routine cleaning and disinfection program
  • 23. 23 Cleaning and Disinfecting Procedures  Routinely clean with a third party “green” certified cleaner and disinfect with an EPA‐registered product with a disinfectant claim for human coronaviruses  Typically, this means daily sanitizing surfaces and objects frequently touched (e.g., bathrooms, water coolers, desks, doorknobs, computer keyboards, hands‐on learning items, faucet handles, phones, toys, etc.)  Clean the surface first to remove all organic matter  Follow the disinfectant manufacturer’s instructions: o Use the proper concentration of disinfectant o Allow the required wet contact time o Pay close attention to hazard warnings and instructions for using personal protective items o Use disinfectants in a sufficiently ventilated space
  • 24. 24 Strategies to Counter Stigma  Rely on and share trusted sources of information.  Speak up if you hear, see, or read stigmatizing or harassing comments or misinformation.  Show compassion and support for individuals and communities more closely impacted.  Avoid stigmatizing people who are in quarantine. They are making the right choice for their communities.  Do not make assumptions about someone’s health status based on their ethnicity, race or national origin. What we can do as individuals
  • 25. 25 Strategies to Counter Stigma  Stay updated and informed on COVID- 19 to avoid miscommunication or inaccurate information  Talk openly about the harm of stigma  View people directly impacted by stigma as people first  Be conscious of your language  Acknowledge access & language barriers  Check your own stigmas and biases  Support community with where to access credible information  Be transparent about COVID-19  Stick to the facts What we can do as professionals Viruses don’t discriminate and neither should we
  • 26. Washington State Department of Health is committed to providing customers with forms and publications in appropriate alternate formats. Requests can be made by calling 800-525-0127 or by email at civil.rights@doh.wa.gov. TTY users dial 711.